Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear
Download results

Showing 161 to 170 of 5459 Results

April 23, 2024 Belgium, United States

Sibelco to enter North American glass recycling industry with acquisition of Strategic Materials, Inc.

Undisclosed

April 19, 2024 Italy, United States

Donaldson and Pelmo87 Shareholders Entered into an Investment Agreement Aimed at the Launch of a Voluntary Tender Offer on Medica

$140 Million

April 18, 2024 France, Netherlands

DIF Capital Partners enters into exclusive negotiations to acquire TDF fibre business

Undisclosed

April 18, 2024 Germany, United Kingdom

SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven

$4.3 Billion

April 17, 2024 France, United Kingdom, United States

Altrad Has Reached an Agreement to Acquire Storks UK Business

Undisclosed

April 16, 2024 United States

UL Standards & Engagement Announces Net Proceeds from UL Solutions Initial Public Offering

$1 Billion

April 15, 2024 Italy

Apheon announces the sale of Italian luxury furniture brand Visionnaire to Forel, the investment vehicle led by Marco Bizzarri (former CEO of Gucci)

Undisclosed

April 12, 2024 France, Morocco

Société Générale Group has reached an agreement with Saham Group for the disposal of Société Générale Marocaine de Banques and La Marocaine Vie

$799.6 Million

April 11, 2024 France

Société Générale has signed a memorandum of understanding with Groupe BPCE with a view to sell Société Générale Equipment Finance’s activities

$1.1 Billion

April 11, 2024 United States

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

$45 Million